India's Supreme Court Rules Against Novartis in Patent Battle
India's Supreme Court has rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures continued access to cheap versions of lifesaving medicines for poor patients worldwide.
This premium content is reserved for New Jersey Law Journal subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now